All News

2068 articles, sorted by publication time.

biology · global

Moderna’s Seven-Antigen Cancer Therapy Advances in the Clinic as the mRNA Tumor Immunity Route Moves Toward More Complex Validation

The therapy, called mRNA-4359, is not a traditional preventive vaccine. Instead, it attempts to make patients’ cells produce multiple tumor-associated antigens, further training the immune system to recognize cancer cells. It has entered Phase 2, but the real test remains whether efficacy signals can move beyond early safety and biological responses toward reproducible clinical benefit.